The investment seeks current income... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FLXN advanced for three days, in of 54 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on November 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FLXN as a result. In of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
FLXN moved below its 50-day moving average on November 13, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for FLXN crossed bearishly below the 50-day moving average on November 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLXN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
a provider of pharmaceutical research and development services
Category HighYieldBond